Westermann C, Wendeler D, Nienhaus A, et al. - In this study population, treatment with a direct-acting antiviral agent (DAA) results in a high sustained virological response (SVR).

• Higher SVR is linked to early viral hepatitis C (HCV) treatment.

• The majority of the people in the study (n = 305) had HP genotype 1 infection.

• The average age was 63 (SD 10), and 77% of the participants were female.

• Two-thirds of the HP had fibrosis or cirrhosis and had received treatment for it.

• Statistically, cirrhosis was shown to be much more common in men than in women.

• It was noted that the end-of-treatment response rate was 99%, while the SVR12 and SVR24 rates were 98%.

• Cirrhosis of the liver was found to be a statistically significant predictor of lower success rates.